27 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
that comply with the requirements applicable to U.S. domestic reporting companies, or individual executive compensation information that is as detailed … with the Board of Directors is responsible for setting our executive compensation and establishing corporate performance objectives. In considering executive
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
that comply with the requirements applicable to U.S. domestic reporting companies, or individual executive compensation information … with the Board of Directors is responsible for setting our executive compensation and establishing corporate performance objectives. In considering executive
424B5
XRTX
XORTX Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
9:57pm
applicable generally to public companies. These provisions include:
reduced executive compensation disclosure;
exemptions from the requirement to hold a non … -binding advisory vote on executive compensation, including golden parachute compensation; and
an exemption from the auditor attestation requirement
424B3
XRTX
XORTX Therapeutics Inc
14 Aug 23
Prospectus supplement
4:42pm
executive compensation disclosure;
exemptions from the requirement to hold a non-binding advisory vote on executive compensation, including golden … companies are also exempt from certain more stringent executive compensation disclosure rules. Thus, even if we no longer qualify as an emerging growth
424B3
t6lm0nd0d4admi6 1x
14 Aug 23
Prospectus supplement
4:40pm
POS AM
pljlz
4 Aug 23
Prospectus update (post-effective amendment)
4:08pm
POS AM
5tvf6
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.2
zec eadz6ni3zar9tl
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.3
stdoek
3 Apr 23
Consolidated Financial Statements
6:05am
S-8
EX-4.2
m2r8t7
27 Oct 22
Registration of securities for employees
7:09pm
424B4
y7u6vy6ch3krdghr19
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
nuzy6v6usv40g v4jd
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
k0joz8 84ndm
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
budkblm3a0gec7gjyx9
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
6pwbpu4qxouzfxyc
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
c8zjjr1 8ny806
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
yefbcd0
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
f0aoxy iqaks1c
13 Apr 22
Current report (foreign)
7:23am